P

Pharmacopeia now Ligand Pharmaceuticals

121 employees

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.

Investor insights

Sectors invested in

Health Care5
Therapeutics4
Biotechnology4
Dermatology3
Drug Formulation2
Medical2
Life Science2
Orphan Diseases2
Pachyonychia Congenita2
Gorlin Syndrome2
Nitric Oxide1
Acne1
Medical Device1

Funding rounds participated in

$10M sweet spot round size

Most of their 5 investments are in rounds between $2.5M and $15M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

1987

Investments made

N

Novan, Inc. raised $15M on July 17, 2023

Investors: Pharmacopeia now Ligand Pharmaceuticals

P

Palvella Therapeutics raised $45M on May 28, 2020

Investors: BioAdvance, Samsara BioCapital, Adams Street Partners, Agent Capital, Nolan Capital, Inc. and Pharmacopeia now Ligand Pharmaceuticals

D

Dianomi Therapeutics raised $3M on February 5, 2019

Investors: Pharmacopeia now Ligand Pharmaceuticals

P

Palvella Therapeutics raised $10M on December 18, 2018

Investors: Pharmacopeia now Ligand Pharmaceuticals

V

Viking Therapeutics, Inc. raised $2.5M on May 26, 2014

Investors: Pharmacopeia now Ligand Pharmaceuticals

Funding rounds raised

P

Pharmacopeia now Ligand Pharmaceuticals raised undisclosed on January 1, 1989

Investors: Venrock

FAQ